Regulatory & Compliance

Federal Officials Align TEFCA and Health Tech Ecosystem
Regulatory & Compliance Federal Officials Align TEFCA and Health Tech Ecosystem

The historical struggle to move patient records between competing hospital systems has long been a primary obstacle to delivering efficient medical care across the United States, yet the landscape in 2026 reflects a transformative shift toward seamless data mobility. Federal officials from the

FTC and Major PBMs Near Settlement Over Insulin Pricing
Regulatory & Compliance FTC and Major PBMs Near Settlement Over Insulin Pricing

The American healthcare landscape is currently witnessing a seismic shift as the Federal Trade Commission (FTC) nears a comprehensive resolution with the nation’s dominant pharmacy benefit managers (PBMs). At the heart of this movement is a concerted effort to dismantle pricing structures that have

CMS Shifts to Mandatory Models to Advance Value-Based Care
Regulatory & Compliance CMS Shifts to Mandatory Models to Advance Value-Based Care

The traditional landscape of American healthcare is undergoing a profound structural realignment as federal payers move away from the polite invitation of voluntary participation toward the firm requirement of mandatory risk. For over a decade, the Centers for Medicare & Medicaid Services (CMS)

CBO Warns Recent Tax Cuts Accelerate Medicare Insolvency to 2040
Regulatory & Compliance CBO Warns Recent Tax Cuts Accelerate Medicare Insolvency to 2040

The sudden realignment of federal fiscal priorities following the 2025 legislative session has sent massive ripples through the American healthcare system, threatening the very foundation of senior care. When the "Big Beautiful Bill" was signed into law in July 2025, proponents celebrated a new era

Is the New CDC Vaccine Schedule a Threat to Public Health?
Regulatory & Compliance Is the New CDC Vaccine Schedule a Threat to Public Health?

A coalition of fifteen states led by prominent attorneys general recently launched a high-stakes legal battle against the federal government, challenging a radical transformation of the national immunization framework that critics argue compromises pediatric safety for political ends. This legal

Will New Laws Shift the Pricing Spotlight to Drugmakers?
Regulatory & Compliance Will New Laws Shift the Pricing Spotlight to Drugmakers?

James Maitland, a distinguished expert in healthcare market dynamics and medical technology, has spent years analyzing the intricate web of pharmacy benefit managers, manufacturers, and regulatory shifts. His work focuses on how technological and legislative changes can dismantle the opaque

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later